Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SHE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STK25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB5R3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RET - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBXA2R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSPG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on